Annual Evidence Update on Lung Cancer: 15-19 November 2010

An update of the evidence on this topic from NHS Evidence - cancer.

This is the fifth Annual Evidence Update on Lung Cancer prepared by NHS Evidence – cancer. It encompasses a guest editorial, expert commentaries, systematic reviews and guidance that have been published since November 2009, on the following topics:

• Causes, risks and prevention
• Screening
• Assessment and diagnosis
• Treatment and disease management
• Service delivery and standards.

Find out more at www.library.nhs.uk/cancer.

Annual Evidence Update on Lung Cancer: 16-20 November 2009

An update of the evidence on this topic from NHS Evidence - cancer.

This is the 5th Annual Evidence Update (AEU) on lung cancer and presents the results of the new evidence that has been published since the previous AEU in November 2008. This year there are a number of interesting commentaries by members of the expert panel. These include:

1. Causes, risks and prevention by John Field and colleagues, Roy Castle, Lung Cancer Research Programme. This highlights socioeconomic factors, respiratory disease risk factors, genetic susceptibility risks and details about a recently developed lung cancer risk prediction modelling tool, currently being assessed in a primary care setting.
2. Biological agents in non-small cell lung cancer by Ekaterini Boleti and Michael Cullen. This commentary provides an overview of the emerging studies in this challenging treatment area and discusses the need for further trials to inform routine practice so that these patients benefit from optimal, cost-effective treatment.
3. Heparin and survival in cancer by Fergus Macbeth. This review looks at the effect of heparin on patients with small cell lung and other types of cancer.
4. Second line chemotherapy for small cell lung cancer by Sarah Danson. The importance of better treatments for relapsed small cell lung cancer is addressed in this commentary.
5. ERS/ESTS taskforce guidelines on fitness for radical surgery by Eric Lim and David Baldwin. New guidelines from Europe have been published on fitness for radical therapy and the authors look at the recommendations and highlight the complexities of the issues addressed.

Find out more at www.library.nhs.uk/cancer.

Annual Evidence Update on Lung Cancer: 17-21 November 2008

An update of the evidence on this topic from the NLH Cancer Specialist Library.

The Cancer Specialist Library will launch its Lung Cancer Annual Evidence Update on 17th November 2008. The update has been divided into sections which will consider:

• Causes, risks and prevention
• Screening
• Assessment and diagnosis
• Service delivery and standards
• Treatment and disease management - Biological therapy
• Treatment and disease management - Chemotherapy
• Treatment and disease management - Radiotherapy
• Treatment and disease management - Surgery
• Treatment and disease management - Symptomatic therapy
• Other therapies
• Palliative care
• Psychosocial, quality of life and follow-up

The resources included in the update are mostly systematic reviews and some guidance published in the preceding year (2007-2008). Where possible we will provide links to the full text and where these are not available to the abstract. The Cancer Specialist Library conducts on-going literature searches and the resources presented in the Annual Evidence Update are the most recently published material that has been indexed in the international databases we search. We welcome feedback about the resources included in this update - do contact us if you would like to comment.

Find out more at http://www.library.nhs.uk/cancer.

National Knowledge Week on Lung Cancer: 19-23 November 2007

The second Lung Cancer NKW will be launched on 19 November and this update will feature a number of new topics as well as updating the literature on others including:

* Second line chemotherapy in Small Cell Lung Cancer
* Prophylactic cranial radiotherapy in extensive stage Small Cell Lung Cancer
* PET scanning & multi-slice CT
* Symptomatic detection in primary care.
* Neo-adjuvant and adjuvant chemotherapy in NSCLC
* Biological and targeted agents
* Screening

The contents for NKWs are developed on the basis of ‘hot topics’ suggested by members of an Advisory Panel who provide high quality summaries which are linked to the latest published evidence. Summaries and resources are organised by topic area and links provided to the relevant guidance, systematic reviews and clinical trials. Full information about contributors is provided, together with a comprehensive resources page with quick links to information about statistics, epidemiology, databases, appraisal tools, clinical trial portals and lung cancer charities.

The Cancer Specialist Library encourages users and contributors to feedback via the ‘contact us’ form on the website.

Find out more at http://www.library.nhs.uk/cancer/Page.aspx?prv=y&pagename=LCA07INT